nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—ABCB1—colon cancer	0.297	1	CbGaD
Amiodarone—CYP2A6—Fluorouracil—colon cancer	0.0596	0.13	CbGbCtD
Amiodarone—CYP3A7—Irinotecan—colon cancer	0.0425	0.0926	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0425	0.0926	CbGbCtD
Amiodarone—CYP3A7—Vincristine—colon cancer	0.0371	0.0809	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0371	0.0809	CbGbCtD
Amiodarone—CYP2C9—Capecitabine—colon cancer	0.0346	0.0754	CbGbCtD
Amiodarone—CYP3A5—Irinotecan—colon cancer	0.0318	0.0694	CbGbCtD
Amiodarone—CYP2C8—Fluorouracil—colon cancer	0.0294	0.0641	CbGbCtD
Amiodarone—CYP3A5—Vincristine—colon cancer	0.0278	0.0607	CbGbCtD
Amiodarone—CYP1A2—Fluorouracil—colon cancer	0.0227	0.0496	CbGbCtD
Amiodarone—ABCB1—Irinotecan—colon cancer	0.0207	0.0452	CbGbCtD
Amiodarone—CYP2C9—Fluorouracil—colon cancer	0.0205	0.0447	CbGbCtD
Amiodarone—ABCB1—Vincristine—colon cancer	0.0181	0.0395	CbGbCtD
Amiodarone—CYP3A4—Irinotecan—colon cancer	0.0124	0.0271	CbGbCtD
Amiodarone—ABCB1—Methotrexate—colon cancer	0.011	0.0239	CbGbCtD
Amiodarone—CYP3A4—Vincristine—colon cancer	0.0109	0.0237	CbGbCtD
Amiodarone—Lucanthone—TOP1—colon cancer	0.00758	0.947	CrCbGaD
Amiodarone—EBP—liver—colon cancer	0.00158	0.0491	CbGeAlD
Amiodarone—THRA—renal system—colon cancer	0.00152	0.0473	CbGeAlD
Amiodarone—THRB—renal system—colon cancer	0.00152	0.0473	CbGeAlD
Amiodarone—CACNA1H—smooth muscle tissue—colon cancer	0.00127	0.0395	CbGeAlD
Amiodarone—THRB—vagina—colon cancer	0.0011	0.0343	CbGeAlD
Amiodarone—CACNA2D2—vagina—colon cancer	0.00109	0.0339	CbGeAlD
Amiodarone—THRB—liver—colon cancer	0.00093	0.0289	CbGeAlD
Amiodarone—THRA—liver—colon cancer	0.00093	0.0289	CbGeAlD
Amiodarone—CYP3A7—liver—colon cancer	0.000795	0.0247	CbGeAlD
Amiodarone—CACNA1H—liver—colon cancer	0.000746	0.0232	CbGeAlD
Amiodarone—SIGMAR1—smooth muscle tissue—colon cancer	0.000724	0.0225	CbGeAlD
Amiodarone—THRA—lymph node—colon cancer	0.000713	0.0222	CbGeAlD
Amiodarone—THRB—lymph node—colon cancer	0.000713	0.0222	CbGeAlD
Amiodarone—CACNA2D2—lymph node—colon cancer	0.000705	0.0219	CbGeAlD
Amiodarone—CYP3A7-CYP3A51P—liver—colon cancer	0.000676	0.021	CbGeAlD
Amiodarone—CYP2A6—vagina—colon cancer	0.000655	0.0204	CbGeAlD
Amiodarone—CACNA1H—lymph node—colon cancer	0.000572	0.0178	CbGeAlD
Amiodarone—KCNH2—renal system—colon cancer	0.000554	0.0172	CbGeAlD
Amiodarone—CYP2A6—liver—colon cancer	0.000552	0.0172	CbGeAlD
Amiodarone—ABCB1—blood vessel—colon cancer	0.000539	0.0168	CbGeAlD
Amiodarone—SIGMAR1—bone marrow—colon cancer	0.000527	0.0164	CbGeAlD
Amiodarone—CYP2C8—renal system—colon cancer	0.000507	0.0158	CbGeAlD
Amiodarone—CYP1A1—epithelium—colon cancer	0.000505	0.0157	CbGeAlD
Amiodarone—SIGMAR1—vagina—colon cancer	0.000505	0.0157	CbGeAlD
Amiodarone—CYP2C19—digestive system—colon cancer	0.000477	0.0148	CbGeAlD
Amiodarone—CYP1A2—renal system—colon cancer	0.000475	0.0148	CbGeAlD
Amiodarone—CYP1A1—renal system—colon cancer	0.000468	0.0146	CbGeAlD
Amiodarone—CYP3A5—renal system—colon cancer	0.000458	0.0142	CbGeAlD
Amiodarone—Dronedarone—ABCB1—colon cancer	0.000427	0.0534	CrCbGaD
Amiodarone—SIGMAR1—liver—colon cancer	0.000426	0.0132	CbGeAlD
Amiodarone—CYP2C19—vagina—colon cancer	0.000421	0.0131	CbGeAlD
Amiodarone—KCNH2—bone marrow—colon cancer	0.000419	0.013	CbGeAlD
Amiodarone—KCNH2—vagina—colon cancer	0.000402	0.0125	CbGeAlD
Amiodarone—CYP1A2—digestive system—colon cancer	0.000389	0.0121	CbGeAlD
Amiodarone—CYP1A1—digestive system—colon cancer	0.000384	0.0119	CbGeAlD
Amiodarone—Agranulocytosis—Fluorouracil—colon cancer	0.000377	0.00215	CcSEcCtD
Amiodarone—CYP3A5—digestive system—colon cancer	0.000376	0.0117	CbGeAlD
Amiodarone—Cardiac failure—Capecitabine—colon cancer	0.000375	0.00214	CcSEcCtD
Amiodarone—CYP2C9—digestive system—colon cancer	0.00037	0.0115	CbGeAlD
Amiodarone—CYP2C8—vagina—colon cancer	0.000367	0.0114	CbGeAlD
Amiodarone—Visual impairment—Irinotecan—colon cancer	0.000365	0.00208	CcSEcCtD
Amiodarone—Disturbance in sexual arousal—Capecitabine—colon cancer	0.000363	0.00207	CcSEcCtD
Amiodarone—Skin exfoliation—Methotrexate—colon cancer	0.000359	0.00204	CcSEcCtD
Amiodarone—CYP2C19—liver—colon cancer	0.000355	0.011	CbGeAlD
Amiodarone—Aplastic anaemia—Methotrexate—colon cancer	0.000353	0.00201	CcSEcCtD
Amiodarone—Flushing—Irinotecan—colon cancer	0.000351	0.002	CcSEcCtD
Amiodarone—Cardiac arrest—Capecitabine—colon cancer	0.000348	0.00199	CcSEcCtD
Amiodarone—Ataxia—Capecitabine—colon cancer	0.000344	0.00196	CcSEcCtD
Amiodarone—CYP3A4—renal system—colon cancer	0.000344	0.0107	CbGeAlD
Amiodarone—Alopecia—Vincristine—colon cancer	0.000343	0.00196	CcSEcCtD
Amiodarone—Ecchymosis—Methotrexate—colon cancer	0.00034	0.00194	CcSEcCtD
Amiodarone—CYP1A1—vagina—colon cancer	0.000339	0.0106	CbGeAlD
Amiodarone—Arrhythmia—Irinotecan—colon cancer	0.000338	0.00193	CcSEcCtD
Amiodarone—CYP2D6—renal system—colon cancer	0.000338	0.0105	CbGeAlD
Amiodarone—Liver function test abnormal—Capecitabine—colon cancer	0.000338	0.00193	CcSEcCtD
Amiodarone—Alopecia—Irinotecan—colon cancer	0.000334	0.00191	CcSEcCtD
Amiodarone—Pulmonary oedema—Methotrexate—colon cancer	0.000334	0.00191	CcSEcCtD
Amiodarone—CYP3A5—vagina—colon cancer	0.000332	0.0103	CbGeAlD
Amiodarone—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00033	0.00188	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00033	0.00188	CcSEcCtD
Amiodarone—Back pain—Vincristine—colon cancer	0.000327	0.00187	CcSEcCtD
Amiodarone—SIGMAR1—lymph node—colon cancer	0.000326	0.0102	CbGeAlD
Amiodarone—Arrhythmia—Fluorouracil—colon cancer	0.000324	0.00185	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000323	0.00184	CcSEcCtD
Amiodarone—Muscular weakness—Capecitabine—colon cancer	0.000323	0.00184	CcSEcCtD
Amiodarone—ABCB1—embryo—colon cancer	0.000321	0.01	CbGeAlD
Amiodarone—Alopecia—Fluorouracil—colon cancer	0.00032	0.00183	CcSEcCtD
Amiodarone—Back pain—Irinotecan—colon cancer	0.000319	0.00182	CcSEcCtD
Amiodarone—Erythema—Fluorouracil—colon cancer	0.000316	0.0018	CcSEcCtD
Amiodarone—Thrombophlebitis—Methotrexate—colon cancer	0.000315	0.0018	CcSEcCtD
Amiodarone—Bronchospasm—Capecitabine—colon cancer	0.000311	0.00177	CcSEcCtD
Amiodarone—Agitation—Vincristine—colon cancer	0.000311	0.00177	CcSEcCtD
Amiodarone—Photosensitivity—Methotrexate—colon cancer	0.00031	0.00177	CcSEcCtD
Amiodarone—CYP2C8—liver—colon cancer	0.00031	0.00964	CbGeAlD
Amiodarone—Angina pectoris—Capecitabine—colon cancer	0.000308	0.00176	CcSEcCtD
Amiodarone—Ill-defined disorder—Irinotecan—colon cancer	0.000306	0.00174	CcSEcCtD
Amiodarone—Vertigo—Vincristine—colon cancer	0.000304	0.00173	CcSEcCtD
Amiodarone—Hepatic failure—Methotrexate—colon cancer	0.000303	0.00173	CcSEcCtD
Amiodarone—Pancytopenia—Capecitabine—colon cancer	0.000301	0.00171	CcSEcCtD
Amiodarone—Vision blurred—Fluorouracil—colon cancer	0.000297	0.0017	CcSEcCtD
Amiodarone—Malaise—Irinotecan—colon cancer	0.000297	0.00169	CcSEcCtD
Amiodarone—Vertigo—Irinotecan—colon cancer	0.000296	0.00169	CcSEcCtD
Amiodarone—Neutropenia—Capecitabine—colon cancer	0.000296	0.00169	CcSEcCtD
Amiodarone—Renal failure acute—Methotrexate—colon cancer	0.000295	0.00168	CcSEcCtD
Amiodarone—CYP1A2—liver—colon cancer	0.00029	0.00902	CbGeAlD
Amiodarone—Dermatitis exfoliative—Methotrexate—colon cancer	0.000289	0.00165	CcSEcCtD
Amiodarone—Photosensitivity reaction—Capecitabine—colon cancer	0.000289	0.00165	CcSEcCtD
Amiodarone—Weight increased—Capecitabine—colon cancer	0.000288	0.00164	CcSEcCtD
Amiodarone—Visual disturbance—Methotrexate—colon cancer	0.000288	0.00164	CcSEcCtD
Amiodarone—Cough—Irinotecan—colon cancer	0.000288	0.00164	CcSEcCtD
Amiodarone—Weight decreased—Capecitabine—colon cancer	0.000286	0.00163	CcSEcCtD
Amiodarone—CYP1A1—liver—colon cancer	0.000286	0.0089	CbGeAlD
Amiodarone—Pneumonia—Capecitabine—colon cancer	0.000284	0.00162	CcSEcCtD
Amiodarone—CYP3A4—digestive system—colon cancer	0.000282	0.00877	CbGeAlD
Amiodarone—Anaphylactoid reaction—Methotrexate—colon cancer	0.000282	0.00161	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00028	0.0016	CcSEcCtD
Amiodarone—CYP3A5—liver—colon cancer	0.00028	0.0087	CbGeAlD
Amiodarone—Renal failure—Capecitabine—colon cancer	0.000277	0.00158	CcSEcCtD
Amiodarone—CYP2D6—digestive system—colon cancer	0.000277	0.00863	CbGeAlD
Amiodarone—Discomfort—Irinotecan—colon cancer	0.000277	0.00158	CcSEcCtD
Amiodarone—Neuropathy peripheral—Capecitabine—colon cancer	0.000277	0.00158	CcSEcCtD
Amiodarone—Oedema—Vincristine—colon cancer	0.000276	0.00157	CcSEcCtD
Amiodarone—Anaphylactic shock—Vincristine—colon cancer	0.000276	0.00157	CcSEcCtD
Amiodarone—CYP2C9—liver—colon cancer	0.000275	0.00857	CbGeAlD
Amiodarone—Jaundice—Capecitabine—colon cancer	0.000275	0.00157	CcSEcCtD
Amiodarone—Infection—Vincristine—colon cancer	0.000274	0.00156	CcSEcCtD
Amiodarone—Confusional state—Irinotecan—colon cancer	0.000271	0.00155	CcSEcCtD
Amiodarone—Thrombocytopenia—Vincristine—colon cancer	0.00027	0.00154	CcSEcCtD
Amiodarone—Anaphylactic shock—Irinotecan—colon cancer	0.000269	0.00153	CcSEcCtD
Amiodarone—Oedema—Irinotecan—colon cancer	0.000269	0.00153	CcSEcCtD
Amiodarone—Infection—Irinotecan—colon cancer	0.000267	0.00152	CcSEcCtD
Amiodarone—Hyperhidrosis—Vincristine—colon cancer	0.000267	0.00152	CcSEcCtD
Amiodarone—Discomfort—Fluorouracil—colon cancer	0.000265	0.00151	CcSEcCtD
Amiodarone—Shock—Irinotecan—colon cancer	0.000265	0.00151	CcSEcCtD
Amiodarone—Agranulocytosis—Capecitabine—colon cancer	0.000263	0.0015	CcSEcCtD
Amiodarone—Thrombocytopenia—Irinotecan—colon cancer	0.000263	0.0015	CcSEcCtD
Amiodarone—Anorexia—Vincristine—colon cancer	0.000263	0.0015	CcSEcCtD
Amiodarone—ABCB1—epithelium—colon cancer	0.000262	0.00816	CbGeAlD
Amiodarone—Hyperhidrosis—Irinotecan—colon cancer	0.00026	0.00148	CcSEcCtD
Amiodarone—KCNH2—lymph node—colon cancer	0.00026	0.00808	CbGeAlD
Amiodarone—Confusional state—Fluorouracil—colon cancer	0.00026	0.00148	CcSEcCtD
Amiodarone—Hypotension—Vincristine—colon cancer	0.000258	0.00147	CcSEcCtD
Amiodarone—Bradycardia—Capecitabine—colon cancer	0.000258	0.00147	CcSEcCtD
Amiodarone—Anaphylactic shock—Fluorouracil—colon cancer	0.000258	0.00147	CcSEcCtD
Amiodarone—Oedema—Fluorouracil—colon cancer	0.000258	0.00147	CcSEcCtD
Amiodarone—Anorexia—Irinotecan—colon cancer	0.000256	0.00146	CcSEcCtD
Amiodarone—Ataxia—Methotrexate—colon cancer	0.000256	0.00146	CcSEcCtD
Amiodarone—Infection—Fluorouracil—colon cancer	0.000256	0.00146	CcSEcCtD
Amiodarone—Hepatitis—Capecitabine—colon cancer	0.000253	0.00144	CcSEcCtD
Amiodarone—Thrombocytopenia—Fluorouracil—colon cancer	0.000252	0.00144	CcSEcCtD
Amiodarone—Liver function test abnormal—Methotrexate—colon cancer	0.000252	0.00143	CcSEcCtD
Amiodarone—Tachycardia—Fluorouracil—colon cancer	0.000251	0.00143	CcSEcCtD
Amiodarone—Hypotension—Irinotecan—colon cancer	0.000251	0.00143	CcSEcCtD
Amiodarone—Insomnia—Vincristine—colon cancer	0.00025	0.00142	CcSEcCtD
Amiodarone—Paraesthesia—Vincristine—colon cancer	0.000248	0.00141	CcSEcCtD
Amiodarone—Anorexia—Fluorouracil—colon cancer	0.000246	0.0014	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000245	0.0014	CcSEcCtD
Amiodarone—Visual impairment—Capecitabine—colon cancer	0.000244	0.00139	CcSEcCtD
Amiodarone—Insomnia—Irinotecan—colon cancer	0.000243	0.00139	CcSEcCtD
Amiodarone—ABCB1—renal system—colon cancer	0.000243	0.00757	CbGeAlD
Amiodarone—Paraesthesia—Irinotecan—colon cancer	0.000241	0.00138	CcSEcCtD
Amiodarone—Hypotension—Fluorouracil—colon cancer	0.000241	0.00137	CcSEcCtD
Amiodarone—Decreased appetite—Vincristine—colon cancer	0.00024	0.00137	CcSEcCtD
Amiodarone—Dyspnoea—Irinotecan—colon cancer	0.00024	0.00137	CcSEcCtD
Amiodarone—Erythema multiforme—Capecitabine—colon cancer	0.00024	0.00137	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Vincristine—colon cancer	0.000238	0.00136	CcSEcCtD
Amiodarone—Fatigue—Vincristine—colon cancer	0.000238	0.00136	CcSEcCtD
Amiodarone—Dyspepsia—Irinotecan—colon cancer	0.000237	0.00135	CcSEcCtD
Amiodarone—Tinnitus—Capecitabine—colon cancer	0.000236	0.00135	CcSEcCtD
Amiodarone—Constipation—Vincristine—colon cancer	0.000236	0.00135	CcSEcCtD
Amiodarone—Pain—Vincristine—colon cancer	0.000236	0.00135	CcSEcCtD
Amiodarone—Flushing—Capecitabine—colon cancer	0.000235	0.00134	CcSEcCtD
Amiodarone—Decreased appetite—Irinotecan—colon cancer	0.000234	0.00133	CcSEcCtD
Amiodarone—Eosinophilia—Methotrexate—colon cancer	0.000233	0.00133	CcSEcCtD
Amiodarone—Insomnia—Fluorouracil—colon cancer	0.000233	0.00133	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Irinotecan—colon cancer	0.000232	0.00132	CcSEcCtD
Amiodarone—Fatigue—Irinotecan—colon cancer	0.000232	0.00132	CcSEcCtD
Amiodarone—Paraesthesia—Fluorouracil—colon cancer	0.000231	0.00132	CcSEcCtD
Amiodarone—Pancreatitis—Methotrexate—colon cancer	0.000231	0.00132	CcSEcCtD
Amiodarone—Pain—Irinotecan—colon cancer	0.00023	0.00131	CcSEcCtD
Amiodarone—Constipation—Irinotecan—colon cancer	0.00023	0.00131	CcSEcCtD
Amiodarone—Dyspnoea—Fluorouracil—colon cancer	0.00023	0.00131	CcSEcCtD
Amiodarone—Dyspepsia—Fluorouracil—colon cancer	0.000227	0.00129	CcSEcCtD
Amiodarone—Arrhythmia—Capecitabine—colon cancer	0.000226	0.00129	CcSEcCtD
Amiodarone—Gastrointestinal pain—Vincristine—colon cancer	0.000226	0.00129	CcSEcCtD
Amiodarone—Decreased appetite—Fluorouracil—colon cancer	0.000224	0.00128	CcSEcCtD
Amiodarone—Alopecia—Capecitabine—colon cancer	0.000224	0.00128	CcSEcCtD
Amiodarone—Pancytopenia—Methotrexate—colon cancer	0.000224	0.00128	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000222	0.00127	CcSEcCtD
Amiodarone—Feeling abnormal—Irinotecan—colon cancer	0.000222	0.00126	CcSEcCtD
Amiodarone—Erythema—Capecitabine—colon cancer	0.000221	0.00126	CcSEcCtD
Amiodarone—Neutropenia—Methotrexate—colon cancer	0.00022	0.00126	CcSEcCtD
Amiodarone—Pain—Fluorouracil—colon cancer	0.00022	0.00126	CcSEcCtD
Amiodarone—Gastrointestinal pain—Irinotecan—colon cancer	0.00022	0.00125	CcSEcCtD
Amiodarone—CYP1A1—lymph node—colon cancer	0.000219	0.00682	CbGeAlD
Amiodarone—Abdominal pain—Vincristine—colon cancer	0.000218	0.00124	CcSEcCtD
Amiodarone—Body temperature increased—Vincristine—colon cancer	0.000218	0.00124	CcSEcCtD
Amiodarone—Erectile dysfunction—Methotrexate—colon cancer	0.000217	0.00124	CcSEcCtD
Amiodarone—Dysgeusia—Capecitabine—colon cancer	0.000216	0.00123	CcSEcCtD
Amiodarone—Photosensitivity reaction—Methotrexate—colon cancer	0.000215	0.00123	CcSEcCtD
Amiodarone—Back pain—Capecitabine—colon cancer	0.000213	0.00122	CcSEcCtD
Amiodarone—Abdominal pain—Irinotecan—colon cancer	0.000213	0.00121	CcSEcCtD
Amiodarone—Body temperature increased—Irinotecan—colon cancer	0.000213	0.00121	CcSEcCtD
Amiodarone—Feeling abnormal—Fluorouracil—colon cancer	0.000212	0.00121	CcSEcCtD
Amiodarone—Pneumonia—Methotrexate—colon cancer	0.000211	0.0012	CcSEcCtD
Amiodarone—CYP3A4—liver—colon cancer	0.00021	0.00653	CbGeAlD
Amiodarone—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000208	0.00119	CcSEcCtD
Amiodarone—Vision blurred—Capecitabine—colon cancer	0.000208	0.00118	CcSEcCtD
Amiodarone—Tremor—Capecitabine—colon cancer	0.000207	0.00118	CcSEcCtD
Amiodarone—CYP2D6—liver—colon cancer	0.000207	0.00643	CbGeAlD
Amiodarone—Renal failure—Methotrexate—colon cancer	0.000207	0.00118	CcSEcCtD
Amiodarone—Ill-defined disorder—Capecitabine—colon cancer	0.000205	0.00117	CcSEcCtD
Amiodarone—Urticaria—Fluorouracil—colon cancer	0.000205	0.00117	CcSEcCtD
Amiodarone—Body temperature increased—Fluorouracil—colon cancer	0.000204	0.00116	CcSEcCtD
Amiodarone—Hypersensitivity—Vincristine—colon cancer	0.000203	0.00116	CcSEcCtD
Amiodarone—ABCB1—lymphoid tissue—colon cancer	0.000202	0.00628	CbGeAlD
Amiodarone—Sweating—Methotrexate—colon cancer	0.000201	0.00115	CcSEcCtD
Amiodarone—ABCB1—digestive system—colon cancer	0.000199	0.00621	CbGeAlD
Amiodarone—Malaise—Capecitabine—colon cancer	0.000199	0.00113	CcSEcCtD
Amiodarone—Vertigo—Capecitabine—colon cancer	0.000198	0.00113	CcSEcCtD
Amiodarone—Hypersensitivity—Irinotecan—colon cancer	0.000198	0.00113	CcSEcCtD
Amiodarone—Asthenia—Vincristine—colon cancer	0.000198	0.00113	CcSEcCtD
Amiodarone—Agranulocytosis—Methotrexate—colon cancer	0.000196	0.00112	CcSEcCtD
Amiodarone—Asthenia—Irinotecan—colon cancer	0.000193	0.0011	CcSEcCtD
Amiodarone—Cough—Capecitabine—colon cancer	0.000192	0.0011	CcSEcCtD
Amiodarone—Hypersensitivity—Fluorouracil—colon cancer	0.00019	0.00108	CcSEcCtD
Amiodarone—Diarrhoea—Vincristine—colon cancer	0.000189	0.00108	CcSEcCtD
Amiodarone—Hepatitis—Methotrexate—colon cancer	0.000189	0.00108	CcSEcCtD
Amiodarone—Anxiety—Capecitabine—colon cancer	0.000187	0.00107	CcSEcCtD
Amiodarone—Discomfort—Capecitabine—colon cancer	0.000185	0.00106	CcSEcCtD
Amiodarone—Diarrhoea—Irinotecan—colon cancer	0.000184	0.00105	CcSEcCtD
Amiodarone—ABCB1—bone marrow—colon cancer	0.000184	0.00572	CbGeAlD
Amiodarone—Dry mouth—Capecitabine—colon cancer	0.000184	0.00105	CcSEcCtD
Amiodarone—Dizziness—Vincristine—colon cancer	0.000183	0.00104	CcSEcCtD
Amiodarone—Pruritus—Fluorouracil—colon cancer	0.000182	0.00104	CcSEcCtD
Amiodarone—Visual impairment—Methotrexate—colon cancer	0.000182	0.00104	CcSEcCtD
Amiodarone—Confusional state—Capecitabine—colon cancer	0.000181	0.00103	CcSEcCtD
Amiodarone—Oedema—Capecitabine—colon cancer	0.00018	0.00103	CcSEcCtD
Amiodarone—Infection—Capecitabine—colon cancer	0.000179	0.00102	CcSEcCtD
Amiodarone—Erythema multiforme—Methotrexate—colon cancer	0.000178	0.00102	CcSEcCtD
Amiodarone—Dizziness—Irinotecan—colon cancer	0.000178	0.00101	CcSEcCtD
Amiodarone—Shock—Capecitabine—colon cancer	0.000177	0.00101	CcSEcCtD
Amiodarone—Diarrhoea—Fluorouracil—colon cancer	0.000176	0.001	CcSEcCtD
Amiodarone—Thrombocytopenia—Capecitabine—colon cancer	0.000176	0.001	CcSEcCtD
Amiodarone—ABCB1—vagina—colon cancer	0.000176	0.00548	CbGeAlD
Amiodarone—Tinnitus—Methotrexate—colon cancer	0.000176	0.001	CcSEcCtD
Amiodarone—Tachycardia—Capecitabine—colon cancer	0.000176	0.001	CcSEcCtD
Amiodarone—Vomiting—Vincristine—colon cancer	0.000176	0.001	CcSEcCtD
Amiodarone—Skin disorder—Capecitabine—colon cancer	0.000175	0.000997	CcSEcCtD
Amiodarone—Rash—Vincristine—colon cancer	0.000174	0.000993	CcSEcCtD
Amiodarone—Hyperhidrosis—Capecitabine—colon cancer	0.000174	0.000992	CcSEcCtD
Amiodarone—Dermatitis—Vincristine—colon cancer	0.000174	0.000992	CcSEcCtD
Amiodarone—Headache—Vincristine—colon cancer	0.000173	0.000986	CcSEcCtD
Amiodarone—Anorexia—Capecitabine—colon cancer	0.000172	0.000978	CcSEcCtD
Amiodarone—Vomiting—Irinotecan—colon cancer	0.000171	0.000975	CcSEcCtD
Amiodarone—Dizziness—Fluorouracil—colon cancer	0.00017	0.000971	CcSEcCtD
Amiodarone—Rash—Irinotecan—colon cancer	0.00017	0.000967	CcSEcCtD
Amiodarone—Dermatitis—Irinotecan—colon cancer	0.000169	0.000966	CcSEcCtD
Amiodarone—Headache—Irinotecan—colon cancer	0.000168	0.00096	CcSEcCtD
Amiodarone—Hypotension—Capecitabine—colon cancer	0.000168	0.000959	CcSEcCtD
Amiodarone—Alopecia—Methotrexate—colon cancer	0.000167	0.00095	CcSEcCtD
Amiodarone—Erythema—Methotrexate—colon cancer	0.000164	0.000936	CcSEcCtD
Amiodarone—Nausea—Vincristine—colon cancer	0.000164	0.000935	CcSEcCtD
Amiodarone—Vomiting—Fluorouracil—colon cancer	0.000164	0.000934	CcSEcCtD
Amiodarone—Insomnia—Capecitabine—colon cancer	0.000163	0.000928	CcSEcCtD
Amiodarone—Rash—Fluorouracil—colon cancer	0.000162	0.000926	CcSEcCtD
Amiodarone—Dermatitis—Fluorouracil—colon cancer	0.000162	0.000925	CcSEcCtD
Amiodarone—Paraesthesia—Capecitabine—colon cancer	0.000162	0.000921	CcSEcCtD
Amiodarone—Headache—Fluorouracil—colon cancer	0.000161	0.00092	CcSEcCtD
Amiodarone—Dysgeusia—Methotrexate—colon cancer	0.000161	0.000917	CcSEcCtD
Amiodarone—Dyspnoea—Capecitabine—colon cancer	0.00016	0.000915	CcSEcCtD
Amiodarone—Nausea—Irinotecan—colon cancer	0.00016	0.000911	CcSEcCtD
Amiodarone—Back pain—Methotrexate—colon cancer	0.000159	0.000905	CcSEcCtD
Amiodarone—Dyspepsia—Capecitabine—colon cancer	0.000158	0.000903	CcSEcCtD
Amiodarone—Decreased appetite—Capecitabine—colon cancer	0.000156	0.000892	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Capecitabine—colon cancer	0.000155	0.000886	CcSEcCtD
Amiodarone—Fatigue—Capecitabine—colon cancer	0.000155	0.000885	CcSEcCtD
Amiodarone—Vision blurred—Methotrexate—colon cancer	0.000155	0.000882	CcSEcCtD
Amiodarone—Pain—Capecitabine—colon cancer	0.000154	0.000877	CcSEcCtD
Amiodarone—Constipation—Capecitabine—colon cancer	0.000154	0.000877	CcSEcCtD
Amiodarone—Nausea—Fluorouracil—colon cancer	0.000153	0.000872	CcSEcCtD
Amiodarone—Ill-defined disorder—Methotrexate—colon cancer	0.000152	0.000868	CcSEcCtD
Amiodarone—ABCB1—liver—colon cancer	0.000149	0.00462	CbGeAlD
Amiodarone—Feeling abnormal—Capecitabine—colon cancer	0.000148	0.000846	CcSEcCtD
Amiodarone—Malaise—Methotrexate—colon cancer	0.000148	0.000844	CcSEcCtD
Amiodarone—Vertigo—Methotrexate—colon cancer	0.000147	0.000841	CcSEcCtD
Amiodarone—Gastrointestinal pain—Capecitabine—colon cancer	0.000147	0.000839	CcSEcCtD
Amiodarone—Cough—Methotrexate—colon cancer	0.000143	0.000817	CcSEcCtD
Amiodarone—Urticaria—Capecitabine—colon cancer	0.000143	0.000815	CcSEcCtD
Amiodarone—Abdominal pain—Capecitabine—colon cancer	0.000142	0.000811	CcSEcCtD
Amiodarone—Body temperature increased—Capecitabine—colon cancer	0.000142	0.000811	CcSEcCtD
Amiodarone—Discomfort—Methotrexate—colon cancer	0.000138	0.000787	CcSEcCtD
Amiodarone—Confusional state—Methotrexate—colon cancer	0.000135	0.00077	CcSEcCtD
Amiodarone—Anaphylactic shock—Methotrexate—colon cancer	0.000134	0.000764	CcSEcCtD
Amiodarone—Infection—Methotrexate—colon cancer	0.000133	0.000759	CcSEcCtD
Amiodarone—Hypersensitivity—Capecitabine—colon cancer	0.000133	0.000756	CcSEcCtD
Amiodarone—Thrombocytopenia—Methotrexate—colon cancer	0.000131	0.000748	CcSEcCtD
Amiodarone—Skin disorder—Methotrexate—colon cancer	0.00013	0.000742	CcSEcCtD
Amiodarone—Hyperhidrosis—Methotrexate—colon cancer	0.00013	0.000738	CcSEcCtD
Amiodarone—Asthenia—Capecitabine—colon cancer	0.000129	0.000736	CcSEcCtD
Amiodarone—Anorexia—Methotrexate—colon cancer	0.000128	0.000728	CcSEcCtD
Amiodarone—Pruritus—Capecitabine—colon cancer	0.000127	0.000726	CcSEcCtD
Amiodarone—Hypotension—Methotrexate—colon cancer	0.000125	0.000714	CcSEcCtD
Amiodarone—Diarrhoea—Capecitabine—colon cancer	0.000123	0.000702	CcSEcCtD
Amiodarone—Insomnia—Methotrexate—colon cancer	0.000121	0.000691	CcSEcCtD
Amiodarone—Paraesthesia—Methotrexate—colon cancer	0.00012	0.000686	CcSEcCtD
Amiodarone—Dyspnoea—Methotrexate—colon cancer	0.000119	0.000681	CcSEcCtD
Amiodarone—Dizziness—Capecitabine—colon cancer	0.000119	0.000679	CcSEcCtD
Amiodarone—Dyspepsia—Methotrexate—colon cancer	0.000118	0.000672	CcSEcCtD
Amiodarone—Decreased appetite—Methotrexate—colon cancer	0.000116	0.000664	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Methotrexate—colon cancer	0.000116	0.000659	CcSEcCtD
Amiodarone—Fatigue—Methotrexate—colon cancer	0.000116	0.000659	CcSEcCtD
Amiodarone—Pain—Methotrexate—colon cancer	0.000115	0.000653	CcSEcCtD
Amiodarone—Vomiting—Capecitabine—colon cancer	0.000114	0.000652	CcSEcCtD
Amiodarone—ABCB1—lymph node—colon cancer	0.000114	0.00354	CbGeAlD
Amiodarone—Rash—Capecitabine—colon cancer	0.000113	0.000647	CcSEcCtD
Amiodarone—Dermatitis—Capecitabine—colon cancer	0.000113	0.000646	CcSEcCtD
Amiodarone—Headache—Capecitabine—colon cancer	0.000113	0.000643	CcSEcCtD
Amiodarone—Feeling abnormal—Methotrexate—colon cancer	0.00011	0.000629	CcSEcCtD
Amiodarone—Gastrointestinal pain—Methotrexate—colon cancer	0.00011	0.000625	CcSEcCtD
Amiodarone—Nausea—Capecitabine—colon cancer	0.000107	0.000609	CcSEcCtD
Amiodarone—Urticaria—Methotrexate—colon cancer	0.000106	0.000607	CcSEcCtD
Amiodarone—Abdominal pain—Methotrexate—colon cancer	0.000106	0.000604	CcSEcCtD
Amiodarone—Body temperature increased—Methotrexate—colon cancer	0.000106	0.000604	CcSEcCtD
Amiodarone—Hypersensitivity—Methotrexate—colon cancer	9.87e-05	0.000563	CcSEcCtD
Amiodarone—Asthenia—Methotrexate—colon cancer	9.61e-05	0.000548	CcSEcCtD
Amiodarone—Pruritus—Methotrexate—colon cancer	9.48e-05	0.00054	CcSEcCtD
Amiodarone—Diarrhoea—Methotrexate—colon cancer	9.17e-05	0.000523	CcSEcCtD
Amiodarone—Dizziness—Methotrexate—colon cancer	8.86e-05	0.000505	CcSEcCtD
Amiodarone—Vomiting—Methotrexate—colon cancer	8.52e-05	0.000486	CcSEcCtD
Amiodarone—Rash—Methotrexate—colon cancer	8.45e-05	0.000482	CcSEcCtD
Amiodarone—Dermatitis—Methotrexate—colon cancer	8.44e-05	0.000481	CcSEcCtD
Amiodarone—Headache—Methotrexate—colon cancer	8.39e-05	0.000479	CcSEcCtD
Amiodarone—Nausea—Methotrexate—colon cancer	7.96e-05	0.000454	CcSEcCtD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—VEGFA—colon cancer	4.92e-05	0.00174	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—BRAF—colon cancer	4.86e-05	0.00172	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CA7—colon cancer	4.81e-05	0.0017	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—SRC—colon cancer	4.75e-05	0.00168	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—colon cancer	4.74e-05	0.00168	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.63e-05	0.00164	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—VEGFA—colon cancer	4.62e-05	0.00163	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—NRAS—colon cancer	4.57e-05	0.00161	CbGpPWpGaD
Amiodarone—EBP—Metabolism—ABCB1—colon cancer	4.53e-05	0.0016	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	4.52e-05	0.0016	CbGpPWpGaD
Amiodarone—CYP1A1—PPARA activates gene expression—PPARG—colon cancer	4.48e-05	0.00158	CbGpPWpGaD
Amiodarone—EBP—Metabolism—TYMS—colon cancer	4.45e-05	0.00157	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CA7—colon cancer	4.41e-05	0.00156	CbGpPWpGaD
Amiodarone—THRA—Generic Transcription Pathway—MYC—colon cancer	4.39e-05	0.00155	CbGpPWpGaD
Amiodarone—THRB—Generic Transcription Pathway—MYC—colon cancer	4.39e-05	0.00155	CbGpPWpGaD
Amiodarone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	4.39e-05	0.00155	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ODC1—colon cancer	4.27e-05	0.00151	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CHST5—colon cancer	4.27e-05	0.00151	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	4.24e-05	0.0015	CbGpPWpGaD
Amiodarone—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	4.22e-05	0.00149	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—EGFR—colon cancer	4.16e-05	0.00147	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—colon cancer	4.03e-05	0.00142	CbGpPWpGaD
Amiodarone—CACNA2D2—Neuronal System—HRAS—colon cancer	4e-05	0.00141	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—DLC1—colon cancer	3.98e-05	0.00141	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	3.95e-05	0.00139	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CA7—colon cancer	3.94e-05	0.00139	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—KRAS—colon cancer	3.93e-05	0.00139	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CHST5—colon cancer	3.91e-05	0.00138	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ODC1—colon cancer	3.91e-05	0.00138	CbGpPWpGaD
Amiodarone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	3.9e-05	0.00138	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CA7—colon cancer	3.84e-05	0.00136	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	3.76e-05	0.00133	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	3.76e-05	0.00133	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—CTNNB1—colon cancer	3.75e-05	0.00132	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—LGR5—colon cancer	3.75e-05	0.00132	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—PPARG—colon cancer	3.71e-05	0.00131	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—PPARG—colon cancer	3.71e-05	0.00131	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	3.65e-05	0.00129	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	3.65e-05	0.00129	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CA7—colon cancer	3.62e-05	0.00128	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CA7—colon cancer	3.59e-05	0.00127	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	3.56e-05	0.00126	CbGpPWpGaD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	3.52e-05	0.00125	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	3.51e-05	0.00124	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—EP300—colon cancer	3.48e-05	0.00123	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.43e-05	0.00121	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—CASP3—colon cancer	3.41e-05	0.0012	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—SRC—colon cancer	3.39e-05	0.0012	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—HRAS—colon cancer	3.34e-05	0.00118	CbGpPWpGaD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	3.34e-05	0.00118	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—VEGFA—colon cancer	3.3e-05	0.00117	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	3.27e-05	0.00116	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	3.26e-05	0.00115	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—NRAS—colon cancer	3.26e-05	0.00115	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	3.25e-05	0.00115	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—ABCB1—colon cancer	3.23e-05	0.00114	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	3.2e-05	0.00113	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	3.2e-05	0.00113	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—TYMS—colon cancer	3.17e-05	0.00112	CbGpPWpGaD
Amiodarone—EBP—Metabolism—PPARG—colon cancer	3.15e-05	0.00111	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	3.13e-05	0.00111	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CHST5—colon cancer	3.09e-05	0.00109	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ODC1—colon cancer	3.09e-05	0.00109	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CA7—colon cancer	3.07e-05	0.00108	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—TGFB1—colon cancer	3.03e-05	0.00107	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	3.02e-05	0.00107	CbGpPWpGaD
Amiodarone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	3.02e-05	0.00107	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—EGFR—colon cancer	2.97e-05	0.00105	CbGpPWpGaD
Amiodarone—CYP1A1—PPARA activates gene expression—EP300—colon cancer	2.93e-05	0.00104	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CHST5—colon cancer	2.92e-05	0.00103	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ODC1—colon cancer	2.92e-05	0.00103	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—VEGFA—colon cancer	2.89e-05	0.00102	CbGpPWpGaD
Amiodarone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	2.87e-05	0.00101	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—KRAS—colon cancer	2.8e-05	0.000991	CbGpPWpGaD
Amiodarone—CYP2A6—NRF2 pathway—TGFB1—colon cancer	2.73e-05	0.000964	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AXIN2—colon cancer	2.69e-05	0.000951	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CHST5—colon cancer	2.67e-05	0.000945	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ODC1—colon cancer	2.67e-05	0.000945	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—TGFB1—colon cancer	2.65e-05	0.000938	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	2.57e-05	0.000908	CbGpPWpGaD
Amiodarone—EBP—Metabolism—PTGS2—colon cancer	2.48e-05	0.000877	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CHST5—colon cancer	2.39e-05	0.000843	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ODC1—colon cancer	2.39e-05	0.000843	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.39e-05	0.000843	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—HRAS—colon cancer	2.38e-05	0.000843	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CA7—colon cancer	2.37e-05	0.000837	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CHST5—colon cancer	2.33e-05	0.000823	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ODC1—colon cancer	2.33e-05	0.000823	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—PPARG—colon cancer	2.25e-05	0.000794	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—HRAS—colon cancer	2.23e-05	0.000789	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CHST5—colon cancer	2.19e-05	0.000776	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ODC1—colon cancer	2.19e-05	0.000776	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ODC1—colon cancer	2.18e-05	0.000769	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CHST5—colon cancer	2.18e-05	0.000769	CbGpPWpGaD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	2.13e-05	0.000753	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—MYC—colon cancer	2.12e-05	0.000748	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—MYC—colon cancer	2.12e-05	0.000748	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—AKT1—colon cancer	2.11e-05	0.000744	CbGpPWpGaD
Amiodarone—EBP—Metabolism—EP300—colon cancer	2.06e-05	0.000729	CbGpPWpGaD
Amiodarone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	1.98e-05	0.000699	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ODC1—colon cancer	1.86e-05	0.000657	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CHST5—colon cancer	1.86e-05	0.000657	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.81e-05	0.00064	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—PTGS2—colon cancer	1.77e-05	0.000625	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.68e-05	0.000594	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.64e-05	0.000578	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.62e-05	0.000573	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.58e-05	0.000559	CbGpPWpGaD
Amiodarone—EBP—Metabolism—PIK3CA—colon cancer	1.53e-05	0.00054	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.51e-05	0.000532	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—EP300—colon cancer	1.47e-05	0.00052	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—AKT1—colon cancer	1.47e-05	0.000518	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—AKT1—colon cancer	1.47e-05	0.000518	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.46e-05	0.000518	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CHST5—colon cancer	1.43e-05	0.000507	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ODC1—colon cancer	1.43e-05	0.000507	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.43e-05	0.000504	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.31e-05	0.000464	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.31e-05	0.000463	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.28e-05	0.000454	CbGpPWpGaD
Amiodarone—EBP—Metabolism—AKT1—colon cancer	1.25e-05	0.000441	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.21e-05	0.000429	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.2e-05	0.000425	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ABCB1—colon cancer	1.13e-05	0.000399	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.11e-05	0.000394	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—TYMS—colon cancer	1.11e-05	0.000392	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.1e-05	0.00039	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—PIK3CA—colon cancer	1.09e-05	0.000384	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.08e-05	0.000381	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ABCB1—colon cancer	1.03e-05	0.000365	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—TYMS—colon cancer	1.02e-05	0.000359	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.85e-06	0.000348	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.47e-06	0.000335	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	9.1e-06	0.000322	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.98e-06	0.000317	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—AKT1—colon cancer	8.89e-06	0.000314	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.68e-06	0.000307	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ABCB1—colon cancer	8.16e-06	0.000288	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—TYMS—colon cancer	8.01e-06	0.000283	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.88e-06	0.000278	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PPARG—colon cancer	7.85e-06	0.000277	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FGFR3—colon cancer	7.77e-06	0.000275	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.75e-06	0.000274	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ABCB1—colon cancer	7.71e-06	0.000272	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.67e-06	0.000271	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—TYMS—colon cancer	7.57e-06	0.000267	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.22e-06	0.000255	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PPARG—colon cancer	7.19e-06	0.000254	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—APC—colon cancer	7.14e-06	0.000252	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—NRAS—colon cancer	7.14e-06	0.000252	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.07e-06	0.00025	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ABCB1—colon cancer	7.06e-06	0.00025	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—TYMS—colon cancer	6.94e-06	0.000245	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—BRAF—colon cancer	6.71e-06	0.000237	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—EGFR—colon cancer	6.5e-06	0.00023	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.44e-06	0.000228	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ABCB1—colon cancer	6.31e-06	0.000223	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PIK3CA—colon cancer	6.21e-06	0.00022	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—TYMS—colon cancer	6.19e-06	0.000219	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTGS2—colon cancer	6.17e-06	0.000218	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—KRAS—colon cancer	6.14e-06	0.000217	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—TYMS—colon cancer	6.04e-06	0.000214	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.04e-06	0.000213	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.88e-06	0.000208	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.83e-06	0.000206	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ABCB1—colon cancer	5.8e-06	0.000205	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ABCB1—colon cancer	5.75e-06	0.000203	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—TYMS—colon cancer	5.7e-06	0.000201	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PPARG—colon cancer	5.67e-06	0.000201	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTGS2—colon cancer	5.66e-06	0.0002	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—TYMS—colon cancer	5.65e-06	0.0002	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CA—colon cancer	5.64e-06	0.000199	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PPARG—colon cancer	5.36e-06	0.000189	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.34e-06	0.000189	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—HRAS—colon cancer	5.22e-06	0.000184	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—EP300—colon cancer	5.14e-06	0.000181	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AKT1—colon cancer	5.08e-06	0.000179	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CASP3—colon cancer	5.03e-06	0.000178	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.02e-06	0.000177	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PPARG—colon cancer	4.91e-06	0.000174	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ABCB1—colon cancer	4.91e-06	0.000174	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCND1—colon cancer	4.89e-06	0.000173	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CTNNB1—colon cancer	4.85e-06	0.000171	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TYMS—colon cancer	4.83e-06	0.000171	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.77e-06	0.000168	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN1A—colon cancer	4.74e-06	0.000167	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—EP300—colon cancer	4.71e-06	0.000166	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AKT1—colon cancer	4.61e-06	0.000163	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EP300—colon cancer	4.51e-06	0.000159	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTGS2—colon cancer	4.46e-06	0.000158	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PPARG—colon cancer	4.39e-06	0.000155	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SRC—colon cancer	4.38e-06	0.000155	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.35e-06	0.000154	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PPARG—colon cancer	4.28e-06	0.000151	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—colon cancer	4.27e-06	0.000151	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTGS2—colon cancer	4.22e-06	0.000149	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NRAS—colon cancer	4.22e-06	0.000149	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PPARG—colon cancer	4.03e-06	0.000143	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PPARG—colon cancer	4e-06	0.000141	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MYC—colon cancer	3.93e-06	0.000139	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TGFB1—colon cancer	3.92e-06	0.000138	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTGS2—colon cancer	3.87e-06	0.000137	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGFR—colon cancer	3.84e-06	0.000136	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CA—colon cancer	3.8e-06	0.000134	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ABCB1—colon cancer	3.79e-06	0.000134	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TYMS—colon cancer	3.72e-06	0.000132	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.71e-06	0.000131	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—EP300—colon cancer	3.71e-06	0.000131	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KRAS—colon cancer	3.63e-06	0.000128	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—EP300—colon cancer	3.51e-06	0.000124	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CA—colon cancer	3.48e-06	0.000123	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTGS2—colon cancer	3.45e-06	0.000122	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PPARG—colon cancer	3.42e-06	0.000121	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTGS2—colon cancer	3.37e-06	0.000119	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CA—colon cancer	3.33e-06	0.000118	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—colon cancer	3.22e-06	0.000114	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—EP300—colon cancer	3.22e-06	0.000114	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTGS2—colon cancer	3.17e-06	0.000112	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTGS2—colon cancer	3.15e-06	0.000111	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AKT1—colon cancer	3.1e-06	0.00011	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HRAS—colon cancer	3.08e-06	0.000109	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—EP300—colon cancer	2.87e-06	0.000101	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AKT1—colon cancer	2.84e-06	0.000101	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—EP300—colon cancer	2.8e-06	9.9e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CA—colon cancer	2.75e-06	9.7e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKT1—colon cancer	2.72e-06	9.62e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTGS2—colon cancer	2.69e-06	9.5e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—EP300—colon cancer	2.64e-06	9.33e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPARG—colon cancer	2.64e-06	9.32e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—EP300—colon cancer	2.62e-06	9.25e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CA—colon cancer	2.59e-06	9.17e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CA—colon cancer	2.38e-06	8.41e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AKT1—colon cancer	2.24e-06	7.93e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—EP300—colon cancer	2.24e-06	7.9e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CA—colon cancer	2.12e-06	7.5e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AKT1—colon cancer	2.12e-06	7.49e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS2—colon cancer	2.08e-06	7.33e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CA—colon cancer	2.07e-06	7.32e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CA—colon cancer	1.95e-06	6.9e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AKT1—colon cancer	1.94e-06	6.87e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CA—colon cancer	1.94e-06	6.84e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKT1—colon cancer	1.73e-06	6.13e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—EP300—colon cancer	1.73e-06	6.1e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKT1—colon cancer	1.69e-06	5.98e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CA—colon cancer	1.65e-06	5.85e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKT1—colon cancer	1.6e-06	5.64e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKT1—colon cancer	1.58e-06	5.59e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKT1—colon cancer	1.35e-06	4.78e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CA—colon cancer	1.28e-06	4.51e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKT1—colon cancer	1.04e-06	3.69e-05	CbGpPWpGaD
